Variation by Race in Antibiotics Prescribed for Hospitalized Patients With Skin and Soft Tissue Infections
Published
December 23, 2021
Source
Alysse G Wurcel , Utibe R Essien, Christina Ortiz, Xiaoqing Fu, Christian Mancini, Yuqing Zhang , Kimberly G Blumenthal
Abstract
Antibiotic prescriptions for skin and soft tissue infection (SSTI) are increasing. SSTI treatment guidelines consider a β-lactam, such as cefazolin, as first-line therapy to target Staphylococcus aureus and Streptococcus species; alternative SSTI treatments, such as clindamycin, are inferior. Racial differences in treatment exist for several medical conditions. However, little is known about disparities in SSTI treatment. We hypothesized that racial differences in the management of SSTI exist.
Posted by
Levy CIMAR